Home › Researcher directory › John N. Gitonga
John N. Gitonga
Affiliation : Kenya Medical Research Institute · KEMRI-Wellcome Trust Research Programme
- 29Publications (affiliation in Kenya)
Research profile
John N. Gitonga has 29 indexed publications (2019–2026). Their work appears mainly in “Wellcome Open Research”, “BMC Infectious Diseases” and “The Lancet Infectious Diseases”. Their most cited article, “Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors” (2020), has been cited 328 times. 4 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in United Kingdom, Brazil, United States, Germany.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsPublications (29)
- Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial
- Low-Dose Yellow Fever Vaccine in Adults in Africa
- Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4–5 June 2024
- Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
- Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial
- SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022
- Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
- Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR
- Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
- SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
- Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21
- Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014–2018: A cohort study
- Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya
- Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
- COVID-19 transmission dynamics underlying epidemic waves in Kenya
- Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
- Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021
- Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya
- Endemic chikungunya fever in Kenyan children: a prospective cohort study
- Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
- Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
- Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
- Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast
- Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
- Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
- An optimisation of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams
- Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast
- Congenital microcephaly unrelated to flavivirus exposure in coastal Kenya
- Complete Genome Sequences of Dengue Virus Type 2 Strains from Kilifi, Kenya
Publication venues
- Wellcome Open Research × 6
- BMC Infectious Diseases × 2
- The Lancet Infectious Diseases × 2
- PLoS ONE × 2
- Science × 2
- Nature Communications × 2
Publications per year
- 20261
- 20252
- 20241
- 20235
- 20225
- 20219
- 20204
- 20192
Collaborations
Partner institutions : University of Oxford · Ministry of Health · London School of Hygiene & Tropical Medicine · Wellcome Trust · Government of Kenya
Co-authors’ countries : United Kingdom · Brazil · United States · Germany
Co-authors
- George M. Warimwe
- Henry Karanja
- Daisy Mugo
- Philip Bejon
- Lynette Isabella Ochola‐Oyier
- Charles N. Agoti
- James Nyagwange
- Ambrose Agweyu
- Benjamin Tsofa
- Mark Otiende
- J. Anthony G. Scott
- Ifedayo Adetifa
Bibliographic data from OpenAlex (open database).
Why choose Dzcademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.